September 2006
Worldwide Biotech;Sep2006, Vol. 18 Issue 9, p5
Trade Publication
The article introduces a gene mutation test kit from DxS. The test kit will be used to identify lung cancer patients who have acquired gene mutations associated with resistance to tyrosine kinase inhibitors. It will also allow drug makers to investigate its association with acquired resistance and can act as a useful tool to predict drug response.


Related Articles

  • Epidermal growth factor receptor mutation in lung adenocarcinoma in India: A single center study. Doval, Dinesh Chandra; Azam, Saud; Batra, Ullas; Choudhury, Kumardeep Dutta; Talwar, Vineet; Gupta, Sunil Kumar; Mehta, Anurag // Journal of Carcinogenesis;2012 Special Issue, p1 

    Background: Adenocarcinoma, a subgroup of non-small cell lung cancer, is the most frequent form occurring in the non-smokers. Mutation in tyrosine kinase domain of epidermal growth factor receptor (EGFR) has been a common feature observed in lung adenocarcinoma. The study was carried out to...

  • Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma. Eun Young Kim; Eun Na Cho; Heae Surng Park; Arum Kim; Ji Young Hong; Seri Lim; Jong Pil Youn; Seung Yong Hwang; Yoon Soo Chang; Kim, Eun Young; Cho, Eun Na; Park, Heae Surng; Kim, Arum; Hong, Ji Young; Lim, Seri; Youn, Jong Pil; Hwang, Seung Yong; Chang, Yoon Soo // BMC Cancer;1/18/2016, Vol. 16, p1 

    Background: Biopsy for lung cancer diagnosis is usually done at a single site. But it is unclear that genetic information at one biopsy site represents that of other lesions and is sufficient for therapeutic decision making. Methods: Non-synonymous mutations and...

  • Lung Cancer in the Era of Targeted Therapy. Zakowski, Maureen F. // Archives of Pathology & Laboratory Medicine;Dec2013, Vol. 137 Issue 12, p1816 

    Context.-The diagnosis and treatment of non-small cell lung cancer have changed dramatically in the past few years. The discovery of activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor and the use of drugs that successfully target those mutations are among...

  • A Rational Diagnostic Algorithm for the Identification of ALK Rearrangement in Lung Cancer: A Comprehensive Study of Surgically Treated Japanese Patients. Takamochi, Kazuya; Takeuchi, Kengo; Hayashi, Takuo; Oh, Shiaki; Suzuki, Kenji // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Background: EML4-ALK fusion gene is found in only a small subset (2–6%) of non-small cell lung cancer. There is an urgent need to establish a rational diagnostic algorithm to identify this rare but important fusion in lung cancer. Methods: We performed a comprehensive analysis of...

  • Lung Cancer: Are we up to the Challenge? Esposito, Luca; Conti, Daniele; Ailavajhala, Ramyasri; Khalil, Nansie; Giordano, Antonio // Current Genomics;Nov2010, Vol. 11 Issue 7, p513 

    Lung cancer is the leading cause of cancer deaths worldwide among both men and women, with more than 1 million deaths annually. Non-small cell lung cancer (NSCLC) accounts for about 80% of all lung cancers. Although recent advances have been made in diagnosis and treatment strategies, the...

  • WS2–4IDENTIFICATION OF ACTIONABLE MUTATIONS IN SPECIMENS FROM PATIENTS WITH LUNG CANCER AT SHIZUOKA CANCER CENTER. Kenmotsu, H.; Koh, Y.; Serizawa, M.; Isaka, M.; Mori, K.; Takahashi, T.; Endo, M.; Nakajima, T.; Ohde, Y.; Yamamoto, N. // Annals of Oncology;Nov2013 Supplement 9, Vol. 24, pix27 

    No abstract available.

  • THE IMPORTANCE OF IMMUNOHISTOCHEMICAL STUDIES OF DIFFERENT MARKERS (CITOKERATIN 7, TTF-1, P63) AND ALK GENE MUTATIONS FOR COMPLETE DIAGNOSIS OF PATIENTS WITH LUNG ADENOCARCINOMA. Suciu, B. A.; Pap, Zsuzsanna; Denes, Lorand; Hălmaciu, Ioana; Mezei, Tibor; Brînzaniuc, Klara; Pavai, Zoltan // Romanian Journal of Functional & Clinical, Macro- & Microscopica;2015, Vol. 14 Issue 2, p127 

    Introduction. One of the main directions of lung cancer research is the study of the molecular biology of the non-small cell lung cancer, of adenocarcinomas in particular. The aim of this study is to highlight the importance of the immunohistochemical markers in patients with lung...

  • Up-Regulation of S100A11 in Lung Adenocarcinoma – Its Potential Relationship with Cancer Progression. Woo, Tetsukan; Okudela, Koji; Mitsui, Hideaki; Tajiri, Michihiko; Rino, Yasushi; Ohashi, Kenichi; Masuda, Munetaka // PLoS ONE;11/6/2015, Vol. 10 Issue 10, p1 

    We previously reported that patients with lung adenocarcinomas with KRAS gene mutations and strong proliferating activity had poorer outcomes, even in the early stage of the disease. The aim of the present study was to elucidate the potential molecular basis of these highly malignant lung tumors...

  • The Diagnostic Value of the Correlation between Serum Anti-p53 Antibody and Positron Emission Tomography Parameters in Lung Cancer. Hasbek, Zekiye; Doğan, Ömer Tamer; Sarı, İsmail; Yücel, Birsen; Şeker, Mehmet Metin; Turgut, Bülent; Berk, Serdar; Siliğ, Yavuz // Molecular Imaging & Radionuclide Therapy;Oct2016, Vol. 25 Issue 3, p107 

    Objective: Mutations in the p53 gene are the most commonly observed genetic abnormalities in malignancies. The purpose of this study was to assess the diagnostic value of serum anti-p53 antibody (Ab) along with the correlation between serum anti-p53 Ab level and quantitative positron emission...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics